What is Foundayo (orforglipron)?
Foundayo (orforglipron) is a once-daily oral GLP-1 weight-loss tablet recently approved by the UK MHRA. Unlike other oral GLP-1 treatments, Foundayo can be taken at any time of day, with or without food or drink, and requires no pre- or post-dose fasting.
When will Foundayo be available at Numan?
Following UK regulatory approval, initial stock is expected to arrive at our pharmacy around Monday 24th August 2026.
We are working closely with our clinical and supply teams to launch Foundayo as soon as stock lands. You can keep an eye on your email or your Numan app for launch announcements and availability.
How much does Foundayo cost?
Pricing details for Foundayo plans are currently being finalised by our commercial team and will be displayed during your online clinical assessment before checkout.
Your monthly subscription plan will include your medication, prescriber reviews, ongoing clinical support, and health coaching.
How is Foundayo delivered and stored?
Once launched, your order will be shipped directly to your door in discreet packaging.
Because Foundayo is a room-temperature tablet, it does not require refrigeration, ice packs, or sharps disposal bins, making it easy and convenient to store at home or take with you when travelling.